TY - JOUR
T1 - CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance
AU - Pitt, Lauren A.
AU - Tikhonova, Anastasia N.
AU - Hu, Hai
AU - Trimarchi, Thomas
AU - King, Bryan
AU - Gong, Yixiao
AU - Sanchez-Martin, Marta
AU - Tsirigos, Aris
AU - Littman, Dan R.
AU - Ferrando, Adolfo A.
AU - Morrison, Sean J.
AU - Fooksman, David R.
AU - Aifantis, Iannis
AU - Schwab, Susan R.
N1 - Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/6/8
Y1 - 2015/6/8
N2 - The role of the microenvironment in Tcell acute lymphoblastic leukemia (T-ALL), or any acute leukemia, is poorly understood. Here we demonstrate that T-ALL cells are in direct, stable contact with CXCL12-producing bone marrow stroma. Cxcl12 deletion from vascular endothelial, but not perivascular, cells impeded tumor growth, suggesting a vascular niche for T-ALL. Moreover, genetic targeting of Cxcr4 in murine T-ALL after disease onset led to rapid, sustained disease remission, and CXCR4 antagonism suppressed human T-ALL in primary xenografts. Loss of CXCR4 targeted key T-ALL regulators, including the MYC pathway, and decreased leukemia initiating cell activity invivo. Our data identify a T-ALL niche and suggest targeting CXCL12/CXCR4 signaling as a powerful therapeutic approach for T-ALL.
AB - The role of the microenvironment in Tcell acute lymphoblastic leukemia (T-ALL), or any acute leukemia, is poorly understood. Here we demonstrate that T-ALL cells are in direct, stable contact with CXCL12-producing bone marrow stroma. Cxcl12 deletion from vascular endothelial, but not perivascular, cells impeded tumor growth, suggesting a vascular niche for T-ALL. Moreover, genetic targeting of Cxcr4 in murine T-ALL after disease onset led to rapid, sustained disease remission, and CXCR4 antagonism suppressed human T-ALL in primary xenografts. Loss of CXCR4 targeted key T-ALL regulators, including the MYC pathway, and decreased leukemia initiating cell activity invivo. Our data identify a T-ALL niche and suggest targeting CXCL12/CXCR4 signaling as a powerful therapeutic approach for T-ALL.
UR - http://www.scopus.com/inward/record.url?scp=84930583383&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930583383&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2015.05.002
DO - 10.1016/j.ccell.2015.05.002
M3 - Article
C2 - 26058075
AN - SCOPUS:84930583383
SN - 1535-6108
VL - 27
SP - 755
EP - 768
JO - Cancer Cell
JF - Cancer Cell
IS - 6
ER -